According to PetIQ's latest financial reports the company has A$0.12 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | A$0.17 B | 14.78% |
2022-12-31 | A$0.14 B | 35.86% |
2021-12-31 | A$0.10 B | 151.73% |
2020-12-31 | A$43.5 M | 11.7% |
2019-12-31 | A$38.95 M | -58.65% |
2018-12-31 | A$94.19 M | 94.06% |
2017-12-31 | A$48.54 M | 4461.87% |
2016-12-31 | A$1.06 M | -76.15% |
2015-12-31 | A$4.46 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
![]() Onconova Therapeutics ONTX | A$25.12 M | -80.52% | ๐บ๐ธ USA |
![]() OPKO Health
OPK | A$0.66 B | 418.24% | ๐บ๐ธ USA |